Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Mangoceuticals, Inc.

Mangoceuticals, Inc. (MGRX) Stock Overview

Explore Mangoceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MGRX●NASDAQ
HealthcareMedical - Healthcare Information Services
$0.52
$0.04(6.58%)
U.S. Market opens in 63h 24m

Mangoceuticals, Inc. (MGRX)

Meyka AI Score

Z

Key Financials

Market Cap5.3M
P/E Ratio-0.30
EPS (TTM)$-1.35
ROE-1.21%
Fundamental Analysis

AI Price Forecasts

1 Month$0.64
3 Months$0.00
1 Year Target$0.00

MGRX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Mangoceuticals, Inc. (NASDAQ: MGRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Mangoceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MGRX on the NASDAQ shows an RSI of 63.75, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Mangoceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.30 and a market capitalization of 5.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MGRX on the NASDAQ.

Price Performance (NASDAQ: MGRX)

1-Day Change
-6.58%
5-Day Change
33.51%
1-Month Change
45.04%
3-Month Change
24.84%
6-Month Change
1.64%
Year-to-Date (YTD) Change
-29.64%
1-Year Change
-70.25%
3-Year Change
-97.45%
5-Year Change
-99.13%
All-Time (Max) Change
-99.13%

Contact Information

https://www.mangoceuticals.com
(214) 242-9619
15110 North Dallas Parkway, Dallas, TX, 75248

Company Facts

30 Employees
IPO DateMar 21, 2023
CountryUS
Actively Trading

Frequently Asked Questions